Who makes Acetaminophen IV Soln?

Acetaminophen IV Soln is developed by Yan Lai.

What development phase is Acetaminophen IV Soln in?

Acetaminophen IV Soln is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Acetaminophen IV Soln

Yan Lai · FDA-approved active Small molecule Quality 3/100

At a glance

Generic name	Acetaminophen IV Soln
Sponsor	Yan Lai
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Determine the Clinical Advantage of IV vs PO Acetaminophen (PHASE4)
The Effectiveness of IV/PO Acetaminophen in the Perioperative Period in Reducing Opiate Use After Lumbar Spine Fusion (PHASE4)
Comparison of Two Routes of Administration of a Multimodal Analgesic Protocol in Postoperative Cesarean Section (PHASE2, PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Acetaminophen IV Soln CI brief — competitive landscape report
Acetaminophen IV Soln updates RSS · CI watch RSS
Yan Lai portfolio CI